News | Digital Radiography (DR) | May 25, 2021

KA Imaging Signs U.S. Distribution Agreement With Alpha Imaging

Alpha Imaging serves 14 states in the Northeast, Mid-Atlantic and Central U.S.

The KA X-ray technology gives doctors a clearer view of a patient's lungs by separating the bone structure (left) and soft tissue (right).

The KA X-ray technology gives doctors a clearer view of a patient's lungs by separating the bone structure (left) and soft tissue (right).

May 25, 2021 - KA Imaging has signed a distribution agreement in the U.S. with Alpha Imaging. Hospitals, medical facilities and practices from 14 states can now acquire the Reveal 35C single exposure, portable, digital dual-​energy subtraction digital radiography (DR) X-ray detector through Alpha Imaging, one of the largest U.S. distributors of medical imaging equipment.

“Our partnership with Alpha is a big step towards KA Imaging’s vision to bring innovative X-ray everywhere," said Robert Moccia, VP of sales for KA Imaging. "Alpha Imaging’s 30+ year track record of providing Imaging equipment to some of the most prestigious healthcare institutions in the U.S. gives KA Imaging the access and credibility to excite the market with our technology and ultimately improve patient care.” 

“The addition of KA Imaging’s Reveal 35C adds yet another advanced imaging technology to our robust portfolio of medical imaging offerings," explained Michael Perrico, CEO of Alpha Imaging. "Single exposure subtracted chest imaging will provide clients with a low dose and cost-effective alternative to traditional dual- energy systems. We are excited to partner with KA Imaging.”

Reveal 35C is the world’s first and only portable dual-energy X-ray detector. The detector provides radiologists with three unobstructed images in a single shot that are free from motion artifacts. Reveal is currently being used in two clinical trials, for detecting both lung cancer and pneumonia (including COVID-19) with great initial success.

Alpha Imaging LLC, headquartered in Ohio, is one of the largest independent sales and service providers of advanced medical imaging equipment in the United States. 

A spin-off from the University of Waterloo, Canada, KA Imaging specializes in developing innovative X-ray imaging technologies and systems, providing solutions to the medical, veterinary, and non-destructive test industrial markets. 

For more information: www.kaimaging.com

Related Content

Researchers have developed an artificial intelligence (AI)-based brain age prediction model to quantify deviations from a healthy brain-aging trajectory in patients with mild cognitive impairment, according to a study published in Radiology: Artificial Intelligence. The model has the potential to aid in early detection of cognitive impairment at an individual level.

Flowchart showing the framework of the brain age prediction model. A, The imaging data were split into training and test datasets. The training dataset consisted of structural magnetic resonance imaging data from 974 healthy individuals, whereas the test dataset included data from 2 groups, 231 healthy controls and 224 aMCI subjects. B, A Conventional Statistical Parametric Mapping structural preprocessing pipeline was used to generate GMV maps in the MNI space. C, The intensity values from the GMV maps were extracted and concatenated to create a feature matrix that was then cleaned and normalized. D, The best elastic net model was obtained by performing supervised learning on the training dataset. To optimize the hyperparameters, a grid search was performed. E, The test dataset was input into the trained model. An age was predicted for every participant included in the test dataset. The PAD scores were calculated by subtracting the participant's chronological age from his or her predicted age. aMCI = amnestic mild cognitive impairment, GMV = gray matter volume, MNI = Montreal Neurologic Institute, Dartel = Diffeomorphic Anatomic Registrations Through Exponentiated Lie Algebra, PAD = predicted age difference. Chart courtesy of Radiological Society of North America

News | Artificial Intelligence | June 23, 2021
June 23, 2021 — Researchers have developed an...
An example of a COVID-19 pneumonia of a chest CT scan. The COVID appears as white ground glass opacities (GGOs) in the lungs. Normal lungs on CT should appear black.

An example of a COVID-19 pneumonia of a chest CT scan. The COVID appears as white ground glass opacities (GGOs) in the lungs. Normal lungs on CT should appear black.

News | Coronavirus (COVID-19) | June 23, 2021
June 23, 2021 — The Radiological Society of North America (...
Led by a Michigan Medicine physician, the research team examined treatment outcomes over two years for patients who fractured their distal radius, the larger of two bones in the forearm. They found no one-size-fits all method for treating the fracture, which more than 85,000 Medicare beneficiaries sustain annually.

Getty Images

News | Radiology Imaging | June 23, 2021
June 23, 2021 — A decade-long...
According to a new study, by the Harvey L. Neiman Health Policy Institute and the American College of Radiology’s National Mammography Database Committee, the most influential radiologist characteristics impacting mammography interpretive performance were geography, breast sub-specialization, performance of diagnostic mammography, and performance of diagnostic ultrasound.

Getty Images

News | Breast Imaging | June 23, 2021
June 23, 2021 — According to a new ...
A phase III clinical trial has validated the effectiveness of the prostate-specific membrane antigen (PSMA)-targeted radiotracer 18F-DCFPyL in detecting and localizing recurrent prostate cancer.

Figure 1. Case example: A 54-year-old man with a history of RP+LND and a subsequent PSA of 1.25 ng/mL had no evidence of disease by baseline imaging. Piflufolastat F 18 (18F-DCFPyL)- PET/CT accurately detected biochemically recurrent prostate cancer with the PSMA PET/CT scan identifying positive left (left panel) and right peri-rectal lymph nodes (right panel).

News | Prostate Cancer | June 21, 2021
June 21, 2021 — A phase III clinica...
The Persona RF PREMIUM is an innovative radiography and fluoroscopy system designed for hospitals and medical centers of all sizes, providing real-time imaging for skeletal, digestive, urinary, respiratory, reproductive systems; and specific organs including the heart, lung and kidneys.
News | Digital Radiography (DR) | June 21, 2021
June 21, 2021 — FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informati
A cardiac MRI of athletes who had COVID-19 is seven times more effective in detecting inflammation of the heart than symptom-based testing, according to a study led by researchers at The Ohio State University Wexner Medical Center and College of Medicine with 12 other Big Ten programs.

Cardiac Magnetic Resonance Imaging in Athletes With Clinical and Subclinical Myocarditis A-D, Athlete A with subclinical possible myocarditis was asymptomatic with normal electrocardiogram (ECG), echocardiogram, and high-sensitivity troponin findings. A, T2 mapping showing elevated T2 in basal-mid inferolateral wall in short axis view. B, late gadolinium enhancement (LGE) in the basal inferolateral wall in short axis view. C, Postcontrast steady state-free precession (SSFP) images showing contrast uptake in the basal-mid inferolateral wall in short axis view. D, LGE in the inferolateral wall in 3-chamber view. E-H, Athlete B with subclinical probable myocarditis was asymptomatic with normal ECG, normal echocardiogram, and elevated high-sensitivity troponin findings. E, T2 mapping showing elevated T2 in the anteroseptal wall in short axis view. F, LGE in the anteroseptal wall in 3-chamber view. G, T2 mapping showing elevated T2 in the anteroseptal wall in 3-chamber view. F, Postcontrast SSFP image showing pericardial effusion in short axis view. I-K, Athlete C with clinical myocarditis and chest pain, dyspnea, abnormal ECG, normal echocardiogram, and normal troponin findings. I, T2 mapping showing elevated T2 in the lateral wall short axis view. J, Postcontrast SSFP images showing contrast uptake in midlateral wall in short axis view. K, LGE in the epicardial midlateral wall in short axis view. L-N, Athlete D with clinical myocarditis, chest pain, abnormal ECG, echocardiogram, and troponin findings. L, T1 mapping showing elevated native T1 in midlateral wall in short axis view. M, T2 mapping showing elevated T2 in the midlateral wall in short axis view. N, LGE in the epicardial midlateral wall in short axis view. IR indicates inferior right view; IRP, inferior, right, posterior view; PLI, posterior, left, inferior view; SL, superior left view; SLA, superior, left, anterior view. Image courtesy of JAMA Cardiol. Published online May 27, 2021. doi:10.1001/jamacardio.2021.2065

News | Cardiac Imaging | June 15, 2021
June 15, 2021 — A...
Rensselaer algorithm can identify risk of cardiovascular disease using lung cancer scan #CT
News | Computed Tomography (CT) | June 14, 2021
June 14, 2021 — Heart disease and cancer are the ...
A new imaging technique has the potential to detect neurological disorders — such as Alzheimer's disease — at their earliest stages, enabling physicians to diagnose and treat patients more quickly. Termed super-resolution, the imaging methodology combines position emission tomography (PET) with an external motion tracking device to create highly detailed images of the brain.

Result of the Hoffman brain phantom study. Top row: same PET slice reconstructed with A) 2mm static OSEM, B) 1mm static OSEM, C) proposed SR method and D) corresponding CT slice (note that the CT image can be treated as a high-resolution reference). Middle row: zoom on region of interest for corresponding images. Bottom row: Line profiles for corresponding data. Image created by Y Chemli, et al., Gordon Center for Medical Imaging: Department of Radiology Massachusetts General Hospital, Harvard Medical School, Boston, MA.

News | PET Imaging | June 14, 2021
June 14, 2021 — A new imaging technique has the potential to detect neurological disorders — such as...